Sandoz Creates New Global Biosimilar Unit
Sandoz has announced the creation of a new biosimilar development, manufacturing and supply unit.
Biopharma
Symbiosis Appoints Joanne Anderson as Chief Commercial Officer
Symbiosis Pharmaceutical Services has appointed experienced commercial leader Joanne Anderson as Chief Commercial Officer to drive global growth following recent capacity investments and expansion plans.
Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy
Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.
Forma Life Sciences Launches US Based CDMO
Forma Life Sciences launches as US-based contract development and manufacturing organization (CDMO) for oral solid dosage development and commercial manufacturing in Irvine, California.
Leading CROs and CDMOs Turn to Mass Photometry for Rapid Protein, mRNA and Viral Vector Analytics
As CROs and CDMOs expand their role in biopharma development and manufacturing, fast, accurate bioanalytic technologies remain critical to biotherapeutic affordability.
DFE Pharma Launches Continuous Manufacturing Platform for Formulation Development
DFE Pharma announces the launch of its continuous manufacturing (CM) platform. It is designed to support pharmaceutical companies in the development, optimization, and lifecycle management of CM processes.
AsymBio Launches End-to-End Tech Platforms for Biopharma Lifecycle
AsymBio, a subsidiary of Asymchem Group, has established integrated technology platforms including cell line development, upstream/downstream processing, conjugation toolbox, and analytics.
Fujifilm Biotechnologies Unveils Biomanufacturing & Process Development UK Expansion
Fujifilm Biotechnologies expanded manufacturing and process development presence in the North East of England to support vital biomanufacturing of innovative medicines and vaccines in the United Kingdom.
Rentschler Biopharma Appoints Veit Bergendahl as COO
Veit Bergendahl will assume operational responsibility for process development, clinical and commercial cGMP manufacturing, engineering and technology as well as automation in production from April 1, 2026.
Sanofi Completes Acquisition of Dynavax for $2.2 Billion
Sanofi has completed its acquisition of Dynavax, adding its adult vaccines and pipeline candidates to strengthen Sanofi’s presence in adult immunization.
WuXi Biologics Boosts Complex Biologics Pipeline
WuXi Biologics partners with Sinorda on bispecific antibodies for autoimmune diseases and HanchorBio on fusion proteins for oncology and immunology.
API Manufacturing
Accelerating API Excellence: Innovation, Quality, and Compliance in Pharmaceutical Manufacturing
From Isolation to Insight: Fluorescence Imaging of EVs in Liquid Biopsy Workflows
This infographic hopes to provide scientists with a comprehensive overview of fluorescence imaging strategies for extracellular vesicle research.
Adapting, Partnering, and Innovating: Insights from CPhI Frankfurt
How CDMOs are navigating uncertainty, forging partnerships, and embracing flexibility.
AstraZeneca to Invest $2 Billion in US Biologics Facility
Fourth major US manufacturing investment announced this year, advancing AstraZeneca’s historic $50 billion commitment to medicines manufacturing and R&D.
Thermo Fisher Opens Advanced Therapies Collaboration Center in Philadelphia
New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies from early research to clinical readiness.
AGC Biologics Partners with Rarity PBC to Commercialize Breakthrough Gene Therapy
AGC Biologics has partnered with Rarity PBC to provide development and GMP manufacturing of a gene therapy aimed at treating a rare, life-threatening immune disorder.
Novartis Launches $23 Billion North Carolina Manufacturing Hub
Novartis plans to establish a flagship manufacturing hub in North Carolina by 2027-2028 as part of a $23 billion investment in US infrastructure.
Navigating the Complexities of Early Drug Development
This infographic provides industry professionals and senior scientists with insights into detailed methodologies for addressing stability challenges in protein therapeutics.
SK Pharmteco Invests $6.1 Million in Peptide Manufacturing at California Facility
SK Pharmteco has announced a $6.1 million investment to expand its Rancho Cordova, California, facility with new lab and kilo-scale capabilities for solid-phase peptide synthesis and purification.
A Balanced Model for the Future of Life Sciences
Following the acquisition of MCE Pharma Brenntag is building a unique position in both traditional pharma and biopharma.
Fujifilm Biotechnologies Opens its Commercial-Scale Cell Culture US Manufacturing Site
Fujifilm Biotechnologies has opened one of North America's largest commercial-scale cell culture biomanufacturing sites in Holly Springs, North Carolina, US.
Symeres Appoints Gabriella Gentile as Chief Operating Officer
Symeres has appointed Gabriella Gentile as Chief Operating Officer to lead global operations and drive transatlantic growth, leveraging her extensive experience in the pharmaceutical and biotech sectors.
Pharma Strategies for Stability
Join us for a dynamic virtual event where science meets strategy.
Siegfried Opens cGMP Viral Vectors Manufacturing Facility
Dinamiqs, a Siegfried company specialized in viral vector design and manufacturing, inaugurated its new cGMP manufacturing facility.
Merck Opens Life Science Production Plant in Ireland
Merck's first climate-neutral production facility has opened at its Blarney site in Cork, Ireland. The €150 million new building is part of the group's €440 million investment program in Ireland.
Roche to Acquire 89Bio in $3.5 Billion Deal
Acquisition supports Roche’s strategy as it enhances the company’s portfolio in cardiovascular, renal, and metabolic diseases (CVRM) and offers optionality for future combination development.
GSK to Invest $30 Billion in US R&D and Manufacturing
Includes $1.2 billion in manufacturing facilities, AI, and advanced digital technologies, creating hundreds of highly skilled US jobs.
Strategic Perspectives on Life Sciences Industry Transformation
Asahi Kasei Life Science emerges as a new growth driver, uniting bioprocess solutions, CRO, and CDMO services to shape the future of healthcare under President Ken Shinomiya’s leadership.
Symeres Acquires DGr Pharma
CRDMO Symeres has acquired DGr Pharma, expanding its capabilities with DGr Pharma’s regulatory and consultancy expertise to provide more comprehensive drug development services.
Oligonucleotide Impurity Analysis Using Hydrophilic Interaction Chromatography (HILIC)
Download this complimentary how-to guide today!
Enhancing Biomolecular Insights with Analytical Ultracentrifugation
This Expert Insights eBook hopes to provide scientists with more information on analytical ultracentrifugation (AUC), allowing you to further your research in this field.
MSD to Acquire Verona Pharma for $10 Billion
MSD, known as Merck & Co. in the US and Canada, recently announced it will acquire Verona Pharma, a biopharmaceutical company focused on respiratory diseases, for approximately $10 billion.
Mabion Launches €500,000 Oncology Services Contest
Mabion, a biotech-focused CDMO offering end-to-end services, has announced the launch of a €500,000 oncology services contest at BIO International Convention 2025.
BASF Opens New GMP Center in Michigan, US
BASF has opened a new Good Manufacturing Practice (GMP) Solution Center in Wyandotte, Michigan, to support the supply of bioprocessing ingredients and excipients for the biopharma and pharmaceutical industries.
